Literature DB >> 4186599

Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon.

S N Wemambu, J L Turk, M F Waters, R J Rees.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4186599     DOI: 10.1016/s0140-6736(69)90592-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  71 in total

Review 1.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Immune complexes and complement hypercatabolism in patients with leprosy.

Authors:  B Bjorvatn; R S Barnetson; G Kronvall; R H Zubler; P H Lambert
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

3.  Reactions following completion of 1 and 2 year multidrug therapy (MDT).

Authors:  Ma Victoria F Balagon; Robert H Gelber; Rodolfo M Abalos; Roland V Cellona
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

4.  Complement activation in leprosy: a retrospective study shows elevated circulating terminal complement complex in reactional leprosy.

Authors:  N Bahia El Idrissi; S Hakobyan; V Ramaglia; A Geluk; B Paul Morgan; P Kumar Das; F Baas
Journal:  Clin Exp Immunol       Date:  2016-03-31       Impact factor: 4.330

5.  Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy.

Authors:  A Castells; J Terencio; A Ramirez; E Sundal; K Bolla
Journal:  Surv Immunol Res       Date:  1985

6.  Prevention of repeated episodes of type 2 reaction of leprosy with the use of thalidomide 100 mg/day.

Authors:  Maria Stella de Mello Ayres Putinatti; Joel Carlos Lastória; Carlos Roberto Padovani
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

7.  Thymus-dependent lymphocytes in leprosy. II. Effect of chemotherapy on T-lymphocyte subpopulations.

Authors:  R N Mshana; A Haregewoin; A Belehu
Journal:  J Clin Immunol       Date:  1982-04       Impact factor: 8.317

8.  Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.

Authors:  R B Narayanan; S Laal; A K Sharma; L K Bhutani; I Nath
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

9.  Tumor necrosis factor production in patients with leprosy.

Authors:  P F Barnes; D Chatterjee; P J Brennan; T H Rea; R L Modlin
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Detection of immune complexes in mice infected with Mycobacterium lepraemurium.

Authors:  J Taverne; M Reichlin; J L Turk; R J Rees
Journal:  Clin Exp Immunol       Date:  1976-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.